The Impact of Actual Body Weight-Based Chemotherapy Dosing and Body Size on Adverse Events and Outcome in Older Patients with Breast Cancer: Results from Cancer and Leukemia Group B (CALGB) Trial 49907 (Alliance A151436)

INTRODUCTION: Actual weight-based (AWB) chemotherapy dosing is recommended for obese patients in the 2012 ASCO Clinical Practice Guideline. CALGB 49907, which utilized ABW-based adjuvant chemotherapy dosing, was a phase 3 trial in women age ≥65 years with early stage breast cancer, providing the opp...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Geriatr Oncol
Autors principals: Morrison, Vicki A., McCall, Linda, Muss, Hyman B., Jatoi, Aminah, Cohen, Harvey J., Cirrincione, Constance T., Ligibel, Jennifer A., Lafky, Jacqueline M., Hurria, Arti
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5936657/
https://ncbi.nlm.nih.gov/pubmed/29233548
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jgo.2017.11.007
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars